ADVANEX INC. Flash Report(Consolidated Basis) --Summary Results for fiscal year ended March 31, 2025
May 14, 2025
Company name: ADVANEX INC. Stock listings: Tokyo Stock Exchange
Code number: 5998 URL https://www.advanex.co.jp Representative: Eitaro Asada, Chairman & President
Inquiries: Tetsuya Yoshihara, Executive Director & CFO Telephone: +81-3-3822-5865
Date of the General Meeting of the Shareholders: June 26, 2025 Expected date of payment for dividends June 27, 2025
Filing date of securities report: June 27, 2025 Supplementary explanation material for financial results Yes
Holding of presentation meeting for financial results Yes
(Figures less than ¥1 million have been omitted.)
-
Performance
-
Operating results
Years ended March 31 Percentages indicate year-on-year increase (decrease).
Net sales
Operating income
Ordinary income
Net income
Millions of yen
%
Millions of yen
%
Millions of yen
%
Millions of yen
%
2025
28,532
7.5
1,109
203.1
170
(79.5)
(628)
-
2024
26,549
7.8
365
497.2
832
42.2
268
347.0
Note: Comprehensive income(millions of yen): Mar. 2025: (113) -% Mar.2024: 1,118 227.7%
Net income per share
Net income per share after dilution
Return on equity
Ratio of ordinary income to total assets
Ratio of operating income to net sales
Yen
Yen
%
%
%
2025
(153.13)
-
(7.7)
0.6
3.9
2024
65.46
65.37
3.5
3.0
1.4
-
Consolidated Financial position
At March 31 (Figures less than ¥1 million have been omitted.)
Total assets
Net assets
Equity ratio
Net assets per share
Millions of yen
Millions of yen
%
Yen
2025
28,505
8,093
28.4
1,969.08
2024
28,457
8,289
29.1
2,016.53
(Reference) Total shareholders' equity: March 31, 2025: ¥8,084 million, March 31, 2024: ¥8,281 million
- Cash flows
Years ended March 31 (Figures less than ¥1 million have been omitted.)
Cash flows from operating activities
Cash flows from investing activities
Cash flows from financing activities
Cash and cash equivalents at end of year
Millions of yen
Millions of yen
Millions of yen
Millions of yen
2025
492
(1,211)
912
4,185
2024
2,048
(640)
(457)
3,981
-
Operating results
-
Dividends
Years ended March 31
Record date
Dividends per share
First quarter
-end dividends
Second quarter
-end dividends
Third quarter
-end dividends
Year-end dividends
Total
Yen
Yen
Yen
Yen
Yen
2024
---
---
---
20.00
20.00
2025
---
---
---
20.00
20.00
2026
(Forecast)
---
--
---
20.00
20.00
Note: The expected dividend amount has not been decided.
Record date
Total amount of dividends
(for the entire fiscal year)
Payout ratio
(consolidated)
Dividends-to-net assets ratio (consolidated)
Millions of yen
%
%
2024
82
30.6
1.1
2025
82
-
1.0
2026
(Forecast)
164.3
-
Forecasts for the Fiscal Year Ended March 31, 2026
Percentages indicate year-on-year increase (decrease).
Net sales
Operating income
Ordinary income
Millions of yen
%
Millions of yen
%
Millions of yen
%
Fiscal year
28,000
(1.9)
500
(54.9)
250
46.5
Net income (loss)
Net income (loss) per share
Millions of yen %
Yen
Fiscal year
50 -
12.18
-
Other
Significant changes in subsidiaries during the subject fiscal year (Transfer of particular subsidiaries following a change in the scope of consolidation): No
Changes in accounting principles, procedures, presentations, etc.
Changes associated with revision of accounting standards, etc: Yes
Changes other than a.: No
Changes in accounting estimates: No
Restatement: No
Number of shares outstanding (Common stock)
Number of shares outstanding at fiscal year-end(including treasury stock): 2025: 4,153,370 shares 2024: 4,153,370 shares
Number of shares of treasury stock at fiscal year-end:
2025: 47,469 shares 2024: 46,761 shares Average Number of outstanding at term-end:
2025: 4,106,318 shares 2024: 4,107,279 shares
(Reference) FLASH REPORT (NON-CONSOLIDATED BASIS)-
Operating results
Years ended March 31 Percentages indicate year-on-year increase (decrease).
Net sales
Operating income
Ordinary income
(loss)
Net income
Millions of yen
%
Millions of yen
%
Millions of yen
%
Millions of yen
%
2025
10,245
2.6
220
82.6
1,346
147.2
586
-
2024
9,985
2.2
120
(31.0)
544
(5.6)
(374) -
Net income per share
Net income per share after dilution
Yen
Yen
2025
142.87
-
2024
（91.06）
-
- Financial position
At March 31
Total assets
Net assets
Equity ratio
Net assets per share
Millions of yen
Millions of yen
%
Yen
2025
17,837
1,489
8.3
360.64
2024
18,086
1,008
5.5
243.53
(Reference) Total shareholders' equity: March 31, 2025 ¥1,480 million, March 31, 2024: ¥1,000 million
Notes
Audit procedures for financial statements under the Financial Instruments and Exchange Law are not completed at the time of disclosure of this Brief Report of Financial Results.
・The business forecasts presented in this report are based on information available to the management at the time of preparation, and are subject to a number of risks and uncertainties. Actual results may differ materially from those projected due to a wide range of factors.
Index
Overview of Business Performance and Financial Position
Overview of Business performance ………………………………...……………………………… 5
Overview of Financial Position …………………………………...……………………………..... 6
The Status of Cash flow 6
Outlook for the coming fiscal year ….….….…….….….…….….….…….….….…….….….…….… 7
Basic Rationale Regarding Selection of Accounting Standards………………………………………… 7
Consolidated Financial Statements
Consolidated Balance Sheets …………………………………….………………………………….. 8
Consolidated Statements of Income and Consolidated Statements of
Comprehensive Income 11
Consolidated Statements of Cash Flows 14
Segment Information 16
-
Operating results
Non-Consolidated Financial Statements
Condensed Non-Consolidated Balance Sheets 17
Condensed Non-Consolidated Statements of Income 20
Overview of Business Performance and Financial Position
Overview of Operating Results for the Fiscal Year under Review
We have operations in 12 countries, including Japan, the Americas, Europe, and Asia. We manufacture and sell precision springs and other metalworking components primarily for automotive, healthcare, OA, and aerospace applications.
In the fiscal year under review, the business climate for automotive applications was sluggish due to the emergence of Chinese manufacturers and the impact of certification fraud. However, sales for OA equipment remained strong, and sales for healthcare, mainly in Europe and the United States, continued to expand steadily.
Under these circumstances, net sales for the fiscal year under review increased 7.5% year on year to ¥28.532 billion, and operating income increased 203.1% to ¥1.109 billion. On the other hand, ordinary income was 170 million yen mainly due to foreign exchange losses (761 million yen) arising from revaluation of assets and liabilities held by us and our overseas consolidated subsidiaries due to exchange rate fluctuations, and net loss attributable to owners of parent was 628 million yen mainly due to special retirement allowance arising from the closure of the plant in Singapore.
Results by business segment are as follows.
[Japan]
Net sales increased 2.6% year on year to ¥9.095 billion due to favorable sales for OA equipment and price increases. Segment income increased 96.9% year on year to ¥222 million.
[Americas]
Sales rose 27.9% to ¥5.41 billion due to a significant increase in production for medical use at our
U.S. plant. Segment profit was ¥192 million, compared with a loss of ¥455 million in the same quarter of the previous fiscal year, due to an increase in profits at the U.S. plant and other factors.
[Europe]
Net sales increased 9.3% year on year to ¥3.399 billion. Segment income decreased 34.7% year on year to ¥150 million, mainly due to an increase in fixed costs resulting from higher personnel and energy costs.
[Asia]
Net sales increased 2.8% compared with the same quarter of the previous fiscal year to ¥10.627 billion due mainly to strong sales for OA equipment. Segment income increased 17.1% to ¥544 million.